RT Journal Article
SR Electronic
T1 Simulation and predictions of a new COVID-19 pandemic wave in Ukraine with the use of generalized SIR model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.13.21264949
DO 10.1101/2021.10.13.21264949
A1 Nesteruk, Igor
YR 2021
UL http://medrxiv.org/content/early/2021/10/18/2021.10.13.21264949.abstract
AB A new wave of the COVID-19 pandemic in Ukraine, which began in the summer of 2021, was characterized by almost exponential growth of smoothed daily numbers of new cases. This is a matter of great concern and the need to immediately predict the dynamics of the epidemic in order to assess the possible maximum values of new cases, the risk of infection and the number of deaths. The generalized SIR-model and corresponding parameter identification procedure was used to simulate and predict the dynamics of this epidemic wave. The new COVID-19 epidemic wave in Ukraine will begin to subside in mid-October 2021, but its duration will be quite long. Unfortunately, new cases may appear by the summer of 2022.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata is listed in the text